Multimodal Cardiovascular and Hepatic Population Imaging

Launched by INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, FRANCE · Mar 25, 2025

Keywords

ClinConnect Summary

The clinical trial titled "Multimodal Cardiovascular and Hepatic Population Imaging" is focused on using advanced medical imaging techniques, like MRI and ultrasound, to study the heart, blood vessels, and liver in healthy individuals. The goal is to gather a large set of medical images and health information from people across France to better understand how different factors—such as age, gender, and genetics—affect our health. This research aims to improve early detection and prevention of diseases that often have no obvious symptoms, particularly heart and liver diseases.

To participate in this study, you need to be at least 20 years old, healthy, and not have any known heart or liver diseases. You should also be part of a social security scheme. Participants will undergo non-invasive imaging tests, which means no surgery is involved, and they will help advance our understanding of health risks in the population. It's important to note that the study is not yet recruiting participants, but it represents an exciting opportunity to contribute to medical research that could benefit everyone.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participation to the Constances cohort
• • Age ≥ 20 years
• • No overt cardiovascular or hepatic disease or related symptoms
• • No known family or personal genetic disease
• • Affiliation with a social security scheme or beneficiary of such a scheme.
• • Agreement to sign the consent
• Exclusion Criteria:
• • Renal function impairment with GFR \< 60 mL/min/1.73m2
• • Deprived of liberty or persons subject to a legal protection measure (under guardianship or trusteeship)
• • People with contraindications to MRI (claustrophobia, presence of metallic elements...)
• • Pregnant or breastfeeding woman (pregnancy urinary test before inclusion for women of childbearing age).